
Smartnilo 0.03mg/0.15mg Tablet
Marketer
Martin & Harris Pvt Ltd
Salt Composition
Ethinyl Estradiol (0.03mg) + Desogestrel (0.15mg)
Overview Smartnilo 0.03mg/0.15mg Tablet
Estrofem 0.03mg/0.15mg tablets combine two medications for birth control and managing irregular menstrual cycles. This medication prevents ovulation and fertilization, potentially lowering ovarian cancer risk. Estrofem can be taken with or without food, but consistent daily timing maximizes effectiveness. Follow your doctor's instructions; typically, the first pill is taken on the first day of your period, continuing daily for a month, then starting a new pack. If vomiting occurs within four hours, take another tablet. Missed doses within 12 hours require condom use for two days. Common side effects include nausea, headaches, breast tenderness, and weight gain. Report concerning or persistent side effects to your doctor; management strategies may be available. Intermenstrual bleeding or missed periods may occur; consult your doctor if this is frequent or prolonged. Seek immediate medical attention if you experience limb swelling and pain, shortness of breath, chest pain, or vision changes, which may indicate a blood clot. Before starting treatment, inform your doctor about smoking (especially if over 35), prior heart attacks, uterine/cervical/vaginal cancers, and all other medications you are taking, as interactions may reduce Estrofem's efficacy. Do not use if pregnant or breastfeeding. Regular monitoring of blood pressure, cholesterol, and blood sugar may be recommended during treatment.
Primary Ingredients of Smartnilo 0.03mg/0.15mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Smartnilo 0.03mg/0.15mg Tablet
Birth control
Major Benefits of Smartnilo 0.03mg/0.15mg Tablet:
Administer Smartnilo 0.03mg/0.15mg Tablet according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Consumption with or without food is acceptable; however, consistent timing is recommended.
Common Side effects of Smartnilo 0.03mg/0.15mg Tablet:
- Nausea
- Stomach pain
- Headache
- Irregular uterine bleeding
- Weight gain
- Breast pain
How to use Smartnilo 0.03mg/0.15mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the Smartnilo 0.03mg/0.15mg Tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, though consistent timing is recommended.
How Smartnilo 0.03mg/0.15mg Tablet works:
Ovuplan 0.03mg/0.15mg tablets are an oral contraceptive. Their mechanism involves suppressing ovulation, hindering sperm motility within the uterus to impede fertilization, and modifying the uterine lining to create an inhospitable environment for implantation.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Smartnilo 0.03mg/0.15mg Tablet with alcohol. Seek medical advice.
PregnancyUNSAFE
Employing Smartnilo 0.03mg/0.15mg tablets during pregnancy presents a considerable risk. Pregnant individuals should consult their physician; research involving animals and pregnant women indicates substantial harm to the fetus.
Breast feedingUNSAFE
Lactation is contraindicated with Smartnilo 0.03mg/0.15mg tablets due to potential infant toxicity. For breastfeeding mothers, particularly within the first month postpartum, non-hormonal or progestin-only birth control methods are recommended.
DrivingSAFE
Driving ability is typically unaffected by Smartnilo 0.03mg/0.15mg Tablets.
KidneyCONSULT YOUR DOCTOR
Data regarding Smartnilo 0.03mg/0.15mg Tablet use in patients with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Smartnilo 0.03mg/0.15mg tablets cautiously, potentially requiring dose modification. Consult a physician for guidance. Smartnilo 0.03mg/0.15mg tablets are contraindicated in patients experiencing severe or active liver disease.
What if you forget to take Smartnilo 0.03mg/0.15mg Tablet :
Omitting a scheduled dose of Smartnilo 0.03mg/0.15mg Tablet warrants immediate physician consultation.
Facts to Know About Smartnilo 0.03mg/0.15mg Tablet
| Label | Value |
|---|---|
| Addictive | No. |
| Treatment Category | Women's Health |
